336 related articles for article (PubMed ID: 28978924)
21. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.
Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z
Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779
[TBL] [Abstract][Full Text] [Related]
22. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
Lu S; Gao Y; Huang X; Wang X
Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
[TBL] [Abstract][Full Text] [Related]
23. Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3.
Boreddy SR; Sahu RP; Srivastava SK
PLoS One; 2011; 6(10):e25799. PubMed ID: 22016776
[TBL] [Abstract][Full Text] [Related]
24. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
Yin W; Xu J; Li C; Dai X; Wu T; Wen J
Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594
[TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1α/VEGF signaling in bladder cancer.
Chen MC; Hsu WL; Chang WL; Chou TC
Sci Rep; 2017 Jul; 7(1):5376. PubMed ID: 28710377
[TBL] [Abstract][Full Text] [Related]
26. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
[TBL] [Abstract][Full Text] [Related]
27. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition.
Xiao H; Tong R; Ding C; Lv Z; Du C; Peng C; Cheng S; Xie H; Zhou L; Wu J; Zheng S
Oncotarget; 2015 Feb; 6(4):2180-92. PubMed ID: 25537504
[TBL] [Abstract][Full Text] [Related]
28. Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells.
Yukawa H; Suzuki K; Aoki K; Arimoto T; Yasui T; Kaji N; Ishikawa T; Ochiya T; Baba Y
Sci Rep; 2018 Apr; 8(1):6765. PubMed ID: 29713019
[TBL] [Abstract][Full Text] [Related]
29. Hovenia dulcis Thunb. and its active compound ampelopsin inhibit angiogenesis through suppression of VEGFR2 signaling and HIF-1α expression.
Han JM; Lim HN; Jung HJ
Oncol Rep; 2017 Dec; 38(6):3430-3438. PubMed ID: 29039561
[TBL] [Abstract][Full Text] [Related]
30. Arsenic Sulfide Inhibits Hepatocellular Carcinoma Metastasis by Suppressing the HIF-1α/VEGF Pathway.
Lu S; Cai Y; Kang T; Zhu C; Feng Z; Chen S
Front Biosci (Landmark Ed); 2023 Jul; 28(7):152. PubMed ID: 37525902
[TBL] [Abstract][Full Text] [Related]
31. Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathway.
Ao JY; Chai ZT; Zhang YY; Zhu XD; Kong LQ; Zhang N; Ye BG; Cai H; Gao DM; Sun HC
Tumour Biol; 2015 Nov; 36(11):8413-24. PubMed ID: 26022159
[TBL] [Abstract][Full Text] [Related]
32. Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway.
Jeon YK; Yoo DR; Jang YH; Jang SY; Nam MJ
Biochim Biophys Acta; 2011 Oct; 1814(10):1340-8. PubMed ID: 21640852
[TBL] [Abstract][Full Text] [Related]
33. Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma.
Cheng CC; Chao WT; Shih JH; Lai YS; Hsu YH; Liu YH
Cancer Chemother Pharmacol; 2021 Jul; 88(1):143-153. PubMed ID: 33860837
[TBL] [Abstract][Full Text] [Related]
34. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
[TBL] [Abstract][Full Text] [Related]
35. PF-04691502 triggers cell cycle arrest, apoptosis and inhibits the angiogenesis in hepatocellular carcinoma cells.
Wang FZ; Peng-Jiao ; Yang NN; Chuang-Yuan ; Zhao YL; Liu QQ; Fei HR; Zhang JG
Toxicol Lett; 2013 Jul; 220(2):150-6. PubMed ID: 23639247
[TBL] [Abstract][Full Text] [Related]
36. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma.
Choi SH; Kwon OJ; Park JY; Kim DY; Ahn SH; Kim SU; Ro SW; Kim KS; Park JH; Kim S; Yun CO; Han KH
Liver Int; 2014 Apr; 34(4):632-42. PubMed ID: 24321089
[TBL] [Abstract][Full Text] [Related]
38. Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3.
Nagaraju GP; Park W; Wen J; Mahaseth H; Landry J; Farris AB; Willingham F; Sullivan PS; Proia DA; El-Hariry I; Taliaferro-Smith L; Diaz R; El-Rayes BF
Angiogenesis; 2013 Oct; 16(4):903-17. PubMed ID: 23838996
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of ERRα inhibits angiogenesis in human umbilical vein endothelial cells through regulating VEGF production and PI3K/Akt/STAT3 signaling pathway.
Zhang LD; Chen L; Zhang M; Qi HJ; Chen L; Chen HF; Zhong MK; Shi XJ; Li QY
Eur J Pharmacol; 2015 Dec; 769():167-76. PubMed ID: 26586335
[TBL] [Abstract][Full Text] [Related]
40. HIF-1α plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression.
Tian H; Huang P; Zhao Z; Tang W; Xia J
Cell Physiol Biochem; 2014; 34(5):1536-46. PubMed ID: 25323032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
